Month: April 2022

Innovation in Gene Therapy Starts at UPMC Children’s

UPMC Children’s is on its way to becoming the lead site for development and human clinical trials of a new gene therapy treatment for VLCADD (Very Long Chain Acyl CoA Dehydrogenase Deficiency), a rare genetic disorder that is identified through newborn screening.

Written by on April 21, 2022